San Diego, CA, United States of America

Michael D Hocker

This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Ambit Biosciences Corporation. Active years: 2015-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael D Hocker. Retrieved from https://idiyas.com/inventor/michael-d-hocker-3y6w0ufz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 66.7


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Michael D Hocker

Introduction

Michael D Hocker is a notable inventor based in San Diego, California. He has made significant contributions to the field of pharmaceuticals, particularly through his work on heterocyclic compounds. With a total of three patents to his name, Hocker's innovations are aimed at addressing critical medical conditions.

Latest Patents

Hocker's latest patents focus on heterocyclic compounds and their methods of use. These compounds are designed for the treatment of diseases mediated by CSF1R, FLT3, KIT, and/or PDGFRβ kinase. The patents also include pharmaceutical compositions that incorporate these compounds, along with methods for their application in medical treatments.

Career Highlights

Michael D Hocker is associated with Ambit Biosciences Corporation, where he continues to advance his research and development efforts. His work has been instrumental in creating new therapeutic options for patients suffering from various kinase-mediated diseases.

Collaborations

Hocker has collaborated with several professionals in his field, including Michael J Hadd and Mark W Holladay. These partnerships have contributed to the success of his projects and the advancement of innovative solutions in the pharmaceutical industry.

Conclusion

Michael D Hocker's contributions to the field of pharmaceuticals through his patents on heterocyclic compounds demonstrate his commitment to innovation and improving healthcare outcomes. His work continues to impact the medical community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…